| Young, Steven |
| Recruiting | 3 | 288 | US | Elagolix 200 MG, Orlissa, Placebo or SOC IVF | Yale University, University of Colorado, Denver, Northwestern University, University of North Carolina, Duke University, Johns Hopkins University | Infertility, Endometriosis | 06/26 | 06/26 | | |
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis |
|
|
| Active, not recruiting | 3 | 112 | US | Elagolix 200 MG, Orlissa, Placebo or SOC IVF | Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina | Infertility, Endometriosis | 05/25 | 05/25 | | |
| Recruiting | 2/3 | 10000 | US | Screening Platform | SWOG Cancer Research Network, National Cancer Institute (NCI) | Previously Treated Non-Small Cell Lung Cancer | 01/29 | 01/29 | | |
NCT05480995: Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI |
|
|
| Recruiting | 2 | 24 | US | 18F-fluorofuranylnorprogesterone PET / MRI | University of North Carolina, Chapel Hill, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Endometriosis | 12/24 | 12/24 | | |
| Stadtmauer, Laurel A |
| Recruiting | 3 | 160 | US | CCT-102 A and CCT-102 B | Conceptra Biosciences, LLC | Early Pregnancy Loss, Delayed Pregnancy Loss | 12/24 | 12/24 | | |
NCT06206746: The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System |
|
|
| Recruiting | N/A | 195 | US | May Health System | May Health | Polycystic Ovary Syndrome, Infertility, Female | 05/25 | 05/28 | | |
| Panek, Tifani |
| Recruiting | 3 | 288 | US | Elagolix 200 MG, Orlissa, Placebo or SOC IVF | Yale University, University of Colorado, Denver, Northwestern University, University of North Carolina, Duke University, Johns Hopkins University | Infertility, Endometriosis | 06/26 | 06/26 | | |
NCT04173169: Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis |
|
|
| Active, not recruiting | 3 | 112 | US | Elagolix 200 MG, Orlissa, Placebo or SOC IVF | Yale University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Colorado, Denver, Northwestern University, University of North Carolina | Infertility, Endometriosis | 05/25 | 05/25 | | |
